CD38 has an enormous potential to be used as a target to inhibit the chronic inflammatory reactions linked to aging and autoimmunity and to eliminate autoreactive plasma cells that produce potentially harmful autoantibodies (5–7). The gene discussed is CD38; the disease is Autoimmunity.